Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma

We identified a glycolysis-related five-gene signature and developed a risk staging model potentially valuable for the clinical management of COAD patients. Our results suggest that prognostic markers based on glycolysis-related genes may be a reliable predictive tool for the prognosis of COAD patients.